VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $201,287 | -10.6% | 7,480 | 0.0% | 0.17% | -6.5% |
| Q2 2023 | $225,223 | -6.9% | 7,480 | 0.0% | 0.18% | -16.0% |
| Q1 2023 | $241,978 | +12.9% | 7,480 | 0.0% | 0.22% | +7.9% |
| Q4 2022 | $214,377 | +4.6% | 7,480 | 0.0% | 0.20% | -4.2% |
| Q2 2022 | $205,000 | -32.6% | 7,480 | -5.7% | 0.21% | -14.5% |
| Q1 2022 | $304,000 | +19.7% | 7,930 | 0.0% | 0.25% | +51.2% |
| Q4 2021 | $254,000 | +12.9% | 7,930 | +3.8% | 0.16% | -2.4% |
| Q3 2021 | $225,000 | -13.5% | 7,640 | 0.0% | 0.17% | -14.3% |
| Q2 2021 | $260,000 | +8.8% | 7,640 | +3.9% | 0.20% | -5.3% |
| Q1 2021 | $239,000 | – | 7,350 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |